Real-world treatment modalities, health care resource utilization, and costs among commercially insured patients with newly diagnosed major depressive disorder in the United States

BACKGROUND: In the United States, major depressive disorder (MDD) is one of the most prevalent mental health disorders. Treatment guidelines for MDD recommend pharmacologic and nonpharmacologic therapies tailored to the patient’s disease severity, level of function, and comorbid health conditions. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Pizzicato, Lia N, Xie, Richard Z, Yang, Yiling, Grabner, Michael, Chapman, Richard H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387971/
https://www.ncbi.nlm.nih.gov/pubmed/37276037
http://dx.doi.org/10.18553/jmcp.2023.29.6.614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387971/
https://www.ncbi.nlm.nih.gov/pubmed/37276037
http://dx.doi.org/10.18553/jmcp.2023.29.6.614

Ejemplares similares